Urine Sample Biobank for Adults Using Intermittent Catheters
Official title: Establishment of a Urine Research Biobank to Explore Basic Urine Characteristics From Adult Intermittent Catheter Users
Run by Coloplast A/S · NCT07769606 · Data updated 2026-11-12
This study tests whether collecting and storing urine samples from adults who use intermittent catheterization, with and without recent UTIs, can build a biobank for future research without changing their standard care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Coloplast A/S Industry-sponsored |
| Locations | 1 site (Humlebæk) |
| Status | Recruiting |
| Started | August 14, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07769606 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who use intermittent catheterization as their primary bladder emptying method and have had 2–5 UTIs in the past year, able and willing to follow study procedures and provide written informed consent.
✕Probably not a fit
Individuals not using intermittent catheterization or those with different urinary tract care needs may not directly benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, non-interventional study that collects urine samples from adult intermittent catheter users who have had recent UTIs and those who have not. Samples will be stored in a research biobank for up to five years after the last patient out, with each participant contributing up to one year of samples or until four complete collections are obtained. Urine collection is done at home or via pickup and does not involve any new medical procedures or devices. Participants complete questionnaires related to UTI episodes and baseline collection. No investigational devices are tested, and standard care remains unchanged throughout the study.
Why it matters
Potential benefit: If successful, the biobank could enable future research to better understand UTIs and catheter-associated risks, potentially guiding improved care.
How similar studies have gone: Previous research leveraging urine biobanks and non-interventional sample collection has supported biobank utility, though this specific IC user population is relatively specialized.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Has given written informed consent * Is at least 18 years old * Has full legal capacity * Is able (assessed by investigator) and willing to adhere to study procedures during study duration. * Has used Intermittent Catheterization (IC) as primary method for bladder emptying for at least a year at time of enrolment. * Has had at least 2 but fewer than 6 self-reported or clinically confirmed Urinary tract Infections in the last year prior to inclusion Exclusion Criteria: * Is participating or plan to participate in any other clinical study with direct relation to the lower urinary tract * Has previously participated in this study * Is currently using prophylactic antibiotic
Where it's running
-
Coloplast research facility
Humlebæk, Denmark Recruiting
Study contacts
- Study coordinator: Mette Krogh
- Email: dkmekr@coloplast.com
- Phone: +4549113245
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risk factors for double-J stent bacterial colonization and its clinical implications
This study looks at which factors make double-J ureteral stents more likely to harbor bacteria and what that means for infections and symptoms.
-
Standing in the shower versus sitting on the toilet to reduce leftover urine after catheter removal in women after benign vaginal surgery
Test whether standing in the shower instead of sitting on the toilet reduces leftover urine and pain after catheter removal in adult women who had benign vaginal gynecologic surgery.
-
D-mannose to prevent recurrent urinary tract infections in post-menopausal women.
This trial will test whether taking 2 g of D-mannose daily prevents recurrent urinary tract infections in post‑menopausal women.
-
Evaluating infection control programs for urinary tract infections at Sohag University Hospital
This study is testing whether a new infection control program can help lower the number of urinary tract infections in adults who need catheters while in the hospital.
-
Evaluating antibiotic use before onabotulinumtoxinA injections for overactive bladder
This study is testing if giving antibiotics before onabotulinumtoxinA injections helps or is needed for adults with overactive bladder who haven't found relief from other treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.